Tissue Perfusion and Blood Flow Monitoring Technology

CW Optics, Inc.1 site in 1 country56 target enrollmentJune 2010

ConditionsWounds and Injuries

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Wounds and Injuries
Sponsor: CW Optics, Inc.
Enrollment: 56
Locations: 1
Primary Endpoint: Effectiveness of blood flow velocity measurements of wound sites to assess tissue viability with a novel optical device. Comparison between the responses of patients treated with hyperbaric oxygen therapy and those treated by other means will be made.
Status: Completed
Last Updated: 12 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to investigate the safety and efficacy of an optical device designed and developed to quantitatively monitor blood flow velocity of wound sites. The hypothesis is that the blood flow velocity of the wound site will provide critical information on the efficacy of hyperbaric oxygen therapy.

Registry

clinicaltrials.gov

Start Date

June 2010

End Date

April 2013

Last Updated

12 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

CW Optics, Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Outcomes

Primary Outcomes

Effectiveness of blood flow velocity measurements of wound sites to assess tissue viability with a novel optical device. Comparison between the responses of patients treated with hyperbaric oxygen therapy and those treated by other means will be made.

Time Frame: 2 years